<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51986">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01944930</url>
  </required_header>
  <id_info>
    <org_study_id>2012-077</org_study_id>
    <nct_id>NCT01944930</nct_id>
  </id_info>
  <brief_title>Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lahey Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lahey Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult patients evaluated at Lahey Clinic with known or suspected gastrointestinal or
      gynecologic malignancies and with an indication for diagnostic laparoscopy will be offered
      participation in the study. The proposed study is a randomized, controlled feasibility trial
      with crossover design. The study's aim is to evaluate the effectiveness of laparoscopic
      narrow band imaging (NBI) compared to standard white-light laparoscopy for detection of
      peritoneal cancer metastases. Study patients will undergo laparoscopic evaluation of the
      peritoneal cavity using a routine white-light videolaparoscope with the capability of NBI.
      The order of white-light and NBI laparoscopy will be randomized for each patient (crossover
      design). Frozen-section histopathology biopsies will be retrieved of all
      suspicious-appearing abnormalities using best clinical practices. The number of detected
      peritoneal metastases will be compared between each diagnostic laparoscopy technique. To
      gauge the rate of potentially missed metastases, peritoneal cancer recurrence will be
      surveyed through a 1-year follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>rate of detectable peritoneal metastases</measure>
    <time_frame>after completion of laparoscopy</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>peritoneal cancer recurrence</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastrointestinal and Gynecologic Malignancies</condition>
  <arm_group>
    <arm_group_label>Narrow Band Imaging Laparoscopy First</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study has single cohort assessed in crossover design. In this arm NBI laparoscopy will be performed first, followed by standard white-light laparoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard White-Light Laparoscopy First</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study has single cohort assessed in crossover design. In this arm standard white-light laparoscopy will be performed first, followed by NBI laparoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laparoscopic narrow band imaging</intervention_name>
    <arm_group_label>Narrow Band Imaging Laparoscopy First</arm_group_label>
    <arm_group_label>Standard White-Light Laparoscopy First</arm_group_label>
    <other_name>Olympus Evis Exera II CV-180 video processor; Olympus Evis Exera II CLV-180 light source; Olympus EndoEYE surgical videoscope</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard white-light laparoscopy</intervention_name>
    <arm_group_label>Narrow Band Imaging Laparoscopy First</arm_group_label>
    <arm_group_label>Standard White-Light Laparoscopy First</arm_group_label>
    <other_name>Olympus Evis Exera II CV-180 video processor; Olympus Evis Exera II CLV-180 light source; Olympus EndoEYE surgical videoscope</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients

          -  diagnosis or suspicion of malignancy of the gastrointestinal or gynecologic tract

        Exclusion Criteria:

          -  clinical contraindication to diagnostic laparoscopy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Schnelldorfer, MD</last_name>
    <role>Study Director</role>
    <affiliation>Lahey Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Schnelldorfer, MD</last_name>
    <phone>781-744-3044</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Lahey Clinic</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Schnelldorfer, MD</last_name>
      <phone>781-744-3044</phone>
    </contact>
    <investigator>
      <last_name>Thomas Schnelldorfer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 25, 2013</lastchanged_date>
  <firstreceived_date>May 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lahey Clinic</investigator_affiliation>
    <investigator_full_name>Desmond H. Birkett</investigator_full_name>
    <investigator_title>Chair, Department of General Surgery, Lahey Medical Center</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
